Baker S, Jiang W, Mou B, Lund CR, et al. Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 Trial. Int J Radiat Oncol Biol Phys 2022;114:617-626.
PMID: 35667528